Nearly 4,000 healthcare stakeholders from 70 countries convened in Baltimore, MD to discuss the latest trends shaping today’s global healthcare system. The conference theme, “Real-World Evidence, Digital Health, and the New Landscape for Health Decision Making,” sparked discussion and debate among policymakers, global thought leaders, researchers and academicians, public and private payers, decision makers, and patient representatives.
In addition to the plenaries and spotlight sessions focused on the conference theme, ISPOR 2018 explored other compelling topics in healthcare, including sessions on patient experience data, value assessment, artificial intelligence, and drug spending in the United States. Describing ISPOR’s role in facilitating an international dialogue on these issues, ISPOR’s Chief Executive Officer and Executive Director Nancy S. Berg noted, “This year’s focus on digital health, real-world evidence, and the changing healthcare landscape could not be more timely. It is gratifying to see that ISPOR is leading at a time when solid approaches to decision making are more important than ever.”
ISPOR, the professional society for health economics and outcomes research, is recognized globally for its scientific conferences, state-of-the-art educational programs, and high-impact journals. For more information, visit www.ispor.org.
